Health
Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease – News-Medical.net
A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment….
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019. Studies have shown that between 3% to 8% of coronavirus disease 2019 (COVID-19) patients have pre-existing chronic liver disease (LD)….
-
Noosa News22 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General20 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News23 hours agoSchoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich
-
General24 hours agoMan dies at shopping centre car park at Charlestown following reports of assault